Paper41454708
Immunomodulatory Fibrous Scaffold with Dual Enzyme-Mimic Activities Prevents Postsurgical Tumor Recurrence.
Zhao X and 9 others. Adv Sci (Weinh), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Immunomodulatory Fibrous Scaffold with Dual Enzyme-Mimic Activities Prevents Postsurgical Tumor Recurrence. Papers, record 41454708. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41454708
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunomodulatory Fibrous Scaffold with Dual Enzyme-Mimic Activities Prevents Postsurgical Tumor Recurrence.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasm Recurrence, Local | Major topic |
| Tissue Scaffolds | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Tumor Microenvironment | |
| Cell Line, Tumor |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 52361165659 | National Natural Science Foundation of China | PubMed | ||
| 52303364 | National Natural Science Foundation of China | PubMed | ||
| 52173271 | National Natural Science Foundation of China | PubMed | ||
| 52221006 | National Natural Science Foundation of China | PubMed | ||
| GZC20250147 | Postdoctoral Fellowship Program of CPSF | PubMed | ||
| 2024M760183 | China Postdoctoral Science Foundation | PubMed |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30531990 | In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment. | Nat Nanotechnol | 2019 | https://conductscience.org/library/papers/30531990 | PubMed |
| 2 | 32627937 | Immunomodulation-Enhanced Nanozyme-Based Tumor Catalytic Therapy. | Adv Mater | 2020 | https://conductscience.org/library/papers/32627937 | PubMed |
| 3 | 31990409 | Manganese Oxide Nanomaterials: Synthesis, Properties, and Theranostic Applications. | Adv Mater | 2020 | https://conductscience.org/library/papers/31990409 | PubMed |
| 4 | 36441901 | Tumor Microenvironment-Activable Manganese-Boosted Catalytic Immunotherapy Combined with PD-1 Checkpoint Blockade. | ACS Nano | 2022 | https://conductscience.org/library/papers/36441901 | PubMed |
| 5 | 36996420 | Bioinspired Mild Photothermal Effect-Reinforced Multifunctional Fiber Scaffolds Promote Bone Regeneration. | ACS Nano | 2023 | https://conductscience.org/library/papers/36996420 | PubMed |
| 6 | 29784994 | Designing natural and synthetic immune tissues. | Nat Mater | 2018 | https://conductscience.org/library/papers/29784994 | PubMed |
| 7 | 36550304 | Systemic enhancement of antitumour immunity by peritumourally implanted immunomodulatory macroporous scaffolds. | Nat Biomed Eng | 2023 | https://conductscience.org/library/papers/36550304 | PubMed |
| 8 | 35595770 | Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis. | Nat Commun | 2022 | https://conductscience.org/library/papers/35595770 | PubMed |
| 9 | 34601760 | 3D Printing Scaffold Vaccine for Antitumor Immunity. | Adv Mater | 2021 | https://conductscience.org/library/papers/34601760 | PubMed |
| 10 | 30328620 | Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies. | CA Cancer J Clin | 2018 | https://conductscience.org/library/papers/30328620 | PubMed |
| 11 | 29488312 | Simultaneous Fenton-like Ion Delivery and Glutathione Depletion by MnO2 -Based Nanoagent to Enhance Chemodynamic Therapy. | Angew Chem Int Ed Engl | 2018 | https://conductscience.org/library/papers/29488312 | PubMed |
| 12 | 37265256 | Melanin-Based Immunoregulatory Nanohybrids Enhance Antitumor Immune Responses in Breast Cancer Mouse Model. | ACS Nano | 2023 | https://conductscience.org/library/papers/37265256 | PubMed |
| 13 | 30713696 | An immunological electrospun scaffold for tumor cell killing and healthy tissue regeneration. | Mater Horiz | 2018 | https://conductscience.org/library/papers/30713696 | PubMed |
| 14 | 29670088 | A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors. | Nat Commun | 2018 | https://conductscience.org/library/papers/29670088 | PubMed |
| 15 | 38280861 | In-situ-sprayed therapeutic hydrogel for oxygen-actuated Janus regulation of postsurgical tumor recurrence/metastasis and wound healing. | Nat Commun | 2024 | https://conductscience.org/library/papers/38280861 | PubMed |
| 16 | 29283170 | Perioperative events influence cancer recurrence risk after surgery. | Nat Rev Clin Oncol | 2018 | https://conductscience.org/library/papers/29283170 | PubMed |
| 17 | 31838435 | Synthetic 3D scaffolds for cancer immunotherapy. | Curr Opin Biotechnol | 2020 | https://conductscience.org/library/papers/31838435 | PubMed |
| 18 | 38301259 | Turning Threat to Therapy: A Nanozyme-Patch in Surgical Bed for Convenient Tumor Vaccination by Sustained In Situ Catalysis. | Adv Healthc Mater | 2024 | https://conductscience.org/library/papers/38301259 | PubMed |
| 19 | 36848115 | Biomineralized MnO2 Nanoplatforms Mediated Delivery of Immune Checkpoint Inhibitors with STING Pathway Activation to Potentiate Cancer Radio-Immunotherapy. | ACS Nano | 2023 | https://conductscience.org/library/papers/36848115 | PubMed |
| 20 | 25739764 | Immunological mechanisms of the antitumor effects of supplemental oxygenation. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/25739764 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CAT | 847 | PubTator's text mining | https://conductscience.org/library/genes/847 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41454708
GET https://conductscience.org/api/papers/v1/41454708/references?page=2